Company page

Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a publicly traded company in the American market, with a market capitalization of approximately $86.3 million. The company focuses on developing innovative therapeutics to improve patient outcomes. Heron is committed to advancing its product pipeline and addressing unmet medical needs in various therapeutic areas.